Considering that changes in IDO1 may also be influenced by the stages of atherosclerotic disease and that IDO1 and the disease may be mutually causative, investigating IDO1-related drug mechanisms at various stages of atherosclerosis is imperative. Here, IDO1 is linked to atherosclerosis.